Over 50 medicines, including those for diabetes, hypertension, vitamins, calcium D3 supplements, bacterial infections, and acid reflux, have failed quality tests conducted by India’s drug regulator.
The Central Drugs Standard Control Organisation (CDSCO) issued a ‘Not of Standard Quality’ (NSQ) alert for August, highlighting that some of the top-selling medicines were produced by well-known pharmaceutical companies, including Alkem Laboratories, Hetero Drugs, Hindustan Antibiotics Limited (HAL), and Karnataka Antibiotics and Pharmaceuticals Ltd.